The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R07 | Other respiratory system products | |
| 3 | R07A | Other respiratory system products | |
| 4 | R07AX | Other respiratory system products | |
| 5 | R07AX30 | Ivacaftor and lumacaftor |
| Active Ingredient | Description | |
|---|---|---|
| Ivacaftor and Lumacaftor |
The combined effect of lumacaftor and ivacaftor is increased quantity and function of F508del |
|
| Lumacaftor |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| ORKAMBI Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ORKAMBI Granules | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
